Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Mischoulon, PH.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01MH074085 (MISCHOULON, DAVID) Mar 9, 2006 - Feb 28, 2012
    NIH/NIMH
    Omega-3 Fatty Acids for Treatment of Major Depression
    Role: Principal Investigator
  2. K23AT001129 (MISCHOULON, DAVID) Sep 27, 2001 - Aug 31, 2007
    NIH/NCCIH
    Omega-3 Fatty Acids in the Treatment of Depression
    Role: Principal Investigator
  3. M01RR001066 (SLAVIN, PETER L) Feb 1, 1978 - May 31, 2008
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Park MJ, Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ. Multiple types of somatic pain increase suicide attempts and depression: A nationwide community sample of Korean adults. Compr Psychiatry. 2018 Dec 19; 90:43-48. PMID: 30684832.
    Citations:    Fields:    
  2. Choi KW, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim DJ, Kim K, Yu HY, Jeon HJ. Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study. J Affect Disord. 2019 Mar 01; 246:157-165. PMID: 30583140.
    Citations:    Fields:    
  3. de Jong M, Belleflamme J, Dale C, Gard T, Gamel C, Mischoulon D, Peeters F. Metabolic Syndrome in Dutch Patients With Bipolar Disorder: A Cross-Sectional Study. Prim Care Companion CNS Disord. 2018 Dec 06; 20(6). PMID: 30549480.
    Citations:    Fields:    Translation:Humans
  4. Sarris J, Byrne GJ, Stough C, Bousman C, Mischoulon D, Murphy J, Macdonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH. Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial. J Affect Disord. 2019 02 15; 245:1007-1015. PMID: 30699842.
    Citations:    Fields:    
  5. Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M. Tachyphylaxis in major depressive disorder: A review of the current state of research. J Affect Disord. 2019 02 15; 245:488-497. PMID: 30439676.
    Citations:    Fields:    
  6. Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, Hamblin MR, Alpert JE, Fava M, Iosifescu DV. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomed Laser Surg. 2018 Oct 20. PMID: 30346890.
    Citations:    Fields:    
  7. Kim H, Choi KW, Na EJ, Hong JP, Fava M, Mischoulon D, Cho H, Jeon HJ. Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adults. Psychiatry Res. 2018 12; 270:257-263. PMID: 30273856.
    Citations:    Fields:    
  8. Choi KW, Na EJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder. Psychiatry Res. 2018 12; 270:246-252. PMID: 30269042.
    Citations:    Fields:    
  9. Cassano P, Dording C, Thomas G, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction. Lasers Surg Med. 2018 Sep 17. PMID: 30221776.
    Citations:    Fields:    
  10. Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. J Affect Disord. 2019 01 15; 243:516-524. PMID: 30286416.
    Citations:    Fields:    
  11. Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression. Front Psychiatry. 2018; 9:424. PMID: 30245644.
    Citations:    
  12. Mischoulon D, Rapaport MH. Current Role of Herbal and Natural Preparations. Handb Exp Pharmacol. 2018 Aug 24. PMID: 30141099.
    Citations:    Fields:    
  13. Sarris J, Byrne GJ, Bousman C, Stough C, Murphy J, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng C, Mischoulon D. Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial. Eur Neuropsychopharmacol. 2018 10; 28(10):1126-1136. PMID: 30115553.
    Citations:    Fields:    
  14. Schuster RM, Pachas GN, Stoeckel L, Cather C, Nadal M, Mischoulon D, Schoenfeld DA, Zhang H, Ulysse C, Dodds EB, Sobolewski S, Hudziak V, Hanly A, Fava M, Evins AE. Phase IIb Trial of an a7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence. J Clin Psychopharmacol. 2018 Aug; 38(4):307-316. PMID: 29912798.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  15. Baek JH, Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Chang SM, Kim JY, Cho H, Jeon HJ. Binge eating, trauma, and suicide attempt in community adults with major depressive disorder. PLoS One. 2018; 13(6):e0198192. PMID: 29927937.
    Citations:    Fields:    Translation:Humans
  16. Okereke OI, Reynolds CF, Mischoulon D, Chang G, Cook NR, Copeland T, Friedenberg G, Buring JE, Manson JE. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. Contemp Clin Trials. 2018 May; 68:133-145. PMID: 29526608.
    Citations:    Fields:    
  17. Nyer M, Gerbarg PL, Silveri MM, Johnston J, Scott TM, Nauphal M, Owen L, Nielsen GH, Mischoulon D, Brown RP, Fava M, Streeter CC. A randomized controlled dosing study of Iyengar yoga and coherent breathing for the treatment of major depressive disorder: Impact on suicidal ideation and safety findings. Complement Ther Med. 2018 Apr; 37:136-142. PMID: 29609926.
    Citations:    Fields:    Translation:Humans
  18. Vance MC, Bui E, Hoeppner SS, Kovachy B, Prescott J, Mischoulon D, Walton ZE, Dong M, Nadal MF, Worthington JJ, Hoge EA, Cassano P, Orr EH, Fava M, de Vivo I, Wong KK, Simon NM. Prospective association between major depressive disorder and leukocyte telomere length over two years. Psychoneuroendocrinology. 2018 04; 90:157-164. PMID: 29499556.
    Citations: 1     Fields:    Translation:HumansCells
  19. Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M, Mischoulon D, Rogers JT. S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life. Neurotherapeutics. 2018 01; 15(1):156-175. PMID: 29340929.
    Citations:    Fields:    
  20. de Jong M, Peeters F, Gard T, Ashih H, Doorley J, Walker R, Rhoades L, Kulich RJ, Kueppenbender KD, Alpert JE, Hoge EA, Britton WB, Lazar SW, Fava M, Mischoulon D. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain. J Clin Psychiatry. 2018 Jan/Feb; 79(1). PMID: 28252881.
    Citations: 1     Fields:    
  21. Moonga SS, Mischoulon D, Winkelman JW, Stern TA. Obstructive Sleep Apnea as a Complication of Bipolar Disorder and Its Treatment: A Review and Approach to Management. Prim Care Companion CNS Disord. 2017 Nov 30; 19(6). PMID: 29195035.
    Citations:    Fields:    Translation:Humans
  22. Kim K, Kim SW, Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Seo SW, Cho H, Seong JK, Jeon HJ. Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder. Sci Rep. 2017 Nov 17; 7(1):15772. PMID: 29150619.
    Citations: 2     Fields:    
  23. Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. J Affect Disord. 2018 02; 227:198. PMID: 29100152.
    Citations:    Fields:    
  24. Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Cho H, Jeon HJ. Alcohol-induced disinhibition is associated with impulsivity, depression, and suicide attempt: A nationwide community sample of Korean adults. J Affect Disord. 2018 02; 227:323-329. PMID: 29132075.
    Citations:    Fields:    Translation:Humans
  25. Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimul. 2018 Jan - Feb; 11(1):75-84. PMID: 29030111.
    Citations:    Fields:    Translation:Humans
  26. Lee HK, Kim JH, Fava M, Mischoulon D, Park JH, Shim EJ, Lee EH, Lee JH, Jeon HJ. Development and validation study of the Smartphone Overuse Screening Questionnaire. Psychiatry Res. 2017 11; 257:352-357. PMID: 28800515.
    Citations:    Fields:    Translation:Humans
  27. Caldieraro MA, McKee M, Leistner-Segal S, Vares EA, Kubaski F, Spanemberg L, Brusius-Facchin AC, Fleck MP, Mischoulon D. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression. World J Biol Psychiatry. 2018 08; 19(5):402-409. PMID: 28656803.
    Citations:    Fields:    Translation:Humans
  28. Heo JY, Yi H, Fava M, Mischoulon D, Kim K, Yoon S, Jeon HJ, Lee JE. Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study. Psychiatry Investig. 2017 Jul; 14(4):491-498. PMID: 28845177.
    Citations:    
  29. Kim DJ, Kim K, Lee HW, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Jeon HJ. Internet Game Addiction, Depression, and Escape From Negative Emotions in Adulthood: A Nationwide Community Sample of Korea. J Nerv Ment Dis. 2017 07; 205(7):568-573. PMID: 28598958.
    Citations: 1     Fields:    Translation:Humans
  30. Yuan H, Mischoulon D, Fava M, Otto MW. Circulating microRNAs as biomarkers for depression: Many candidates, few finalists. J Affect Disord. 2018 06; 233:68-78. PMID: 28673667.
    Citations:    Fields:    Translation:HumansAnimalsCells
  31. Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter LL, Lavretsky H, Muskin PR, Brown RP, Mischoulon D. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. J Clin Psychiatry. 2017 Jun; 78(6):e656-e667. PMID: 28682528.
    Citations: 4     Fields:    Translation:Humans
  32. Kim K, Lee H, Hong JP, Cho MJ, Fava M, Mischoulon D, Kim DJ, Jeon HJ. Poor sleep quality and suicide attempt among adults with internet addiction: A nationwide community sample of Korea. PLoS One. 2017; 12(4):e0174619. PMID: 28384238.
    Citations:    Fields:    Translation:Humans
  33. Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study. J Clin Psychiatry. 2017 04; 78(4):449-455. PMID: 27835715.
    Citations: 1     Fields:    Translation:Humans
  34. Freeman MP, Pooley J, Flynn MJ, Baer L, Mischoulon D, Mou D, Fava M. Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials. J Clin Psychopharmacol. 2017 Apr; 37(2):176-181. PMID: 28187008.
    Citations: 1     Fields:    Translation:Humans
  35. Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M. Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation. Aust N Z J Psychiatry. 2017 Jan; 51(1):55-64. PMID: 26893373.
    Citations: 6     Fields:    Translation:Humans
  36. Baek JH, Kim JH, Kim BN, Park SJ, Fava M, Mischoulon D, Lee D, Jeon HJ. Comparisons of Subthreshold Versus Full Posttraumatic Stress Disorder Distinguished by Subjective Functional Impairment Among Train Drivers: A Population-Based Nationwide Study in South Korea. Psychiatry Investig. 2017 Jan; 14(1):1-7. PMID: 28096868.
    Citations:    
  37. Heo JY, Kim K, Fava M, Mischoulon D, Papakostas GI, Kim MJ, Kim DJ, Chang KJ, Oh Y, Yu BH, Jeon HJ. Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison. J Psychiatr Res. 2017 04; 87:61-70. PMID: 28017916.
    Citations: 3     Fields:    Translation:Humans
  38. Jeon HJ, Woo JM, Kim HJ, Fava M, Mischoulon D, Cho SJ, Chang SM, Park DH, Kim JW, Yoo I, Heo JY, Hong JP. Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder. Psychiatry Investig. 2016 Nov; 13(6):609-615. PMID: 27909451.
    Citations: 3     
  39. Greenberg J, Shapero BG, Mischoulon D, Lazar SW. Mindfulness-based cognitive therapy for depressed individuals improves suppression of irrelevant mental-sets. Eur Arch Psychiatry Clin Neurosci. 2017 Apr; 267(3):277-282. PMID: 27830339.
    Citations: 1     Fields:    Translation:Humans
  40. Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. J Affect Disord. 2017 01 15; 208:6-14. PMID: 27736689.
    Citations: 1     Fields:    Translation:Humans
  41. Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, Simon NM. Inflammatory cytokines in major depressive disorder: A case-control study. Aust N Z J Psychiatry. 2017 Jan; 51(1):23-31. PMID: 27313138.
    Citations:    Fields:    Translation:Humans
  42. Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016 10; 21(10):1483-4. PMID: 27528461.
    Citations: 4     Fields:    
  43. Chang KJ, Kim K, Fava M, Mischoulon D, Hong JP, Kim DJ, Heo JY, Choi H, Jeon HJ. Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder. Psychiatry Res. 2016 11 30; 245:127-132. PMID: 27541348.
    Citations:    Fields:    Translation:Humans
  44. Mischoulon D, Zajecka J, Freeman MP, Fava M. Does folic acid interfere with lamotrigine? Lancet Psychiatry. 2016 Aug; 3(8):704-5. PMID: 27475760.
    Citations:    Fields:    
  45. de Jong M, Lazar SW, Hug K, Mehling WE, Hölzel BK, Sack AT, Peeters F, Ashih H, Mischoulon D, Gard T. Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression. Front Psychol. 2016; 7:967. PMID: 27445929.
    Citations: 6     
  46. Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Heo JY, Kim KW, Kim ST, Kim DJ, Kim DK, Seo SW, Seong JK, Jeon HJ. Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder. Transl Psychiatry. 2016 06 07; 6(6):e835. PMID: 27271861; PMCID: PMC4931608.
    Citations: 6     Fields:    Translation:Humans
  47. Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ. Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood. J Affect Disord. 2016 10; 203:275-280. PMID: 27314814.
    Citations: 2     Fields:    Translation:Humans
  48. Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. J Clin Psychiatry. 2016 06; 77(6):e719-25. PMID: 27232360.
    Citations: 9     Fields:    Translation:Humans
  49. Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ. Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder. Psychiatry Investig. 2016 May; 13(3):321-6. PMID: 27247599; PMCID: PMC4878967.
    Citations: 2     
  50. Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Am J Psychiatry. 2016 Jun 01; 173(6):575-87. PMID: 27113121.
    Citations: 21     Fields:    Translation:Humans
  51. Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016 10; 21(10):1372-80. PMID: 26643541.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  52. Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Lee DW, Heo JY, Jeon HJ. Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults. J Affect Disord. 2016 Feb; 191:222-9. PMID: 26682491.
    Citations:    Fields:    Translation:Humans
  53. Sarris J, Logan AC, Akbaraly TN, Paul Amminger G, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Parletta N, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry. 2015 Oct; 14(3):370-1. PMID: 26407799; PMCID: PMC4592666.
    Citations: 5     
  54. Cassano P, Trinh NH, Chang T, Cusin C, Fisher L, Pedrelli P, Nyer M, Kim DJ, Alpert J, Mischoulon D. Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms. J Nerv Ment Dis. 2015 Oct; 203(10):769-73. PMID: 26356091.
    Citations:    Fields:    Translation:Humans
  55. Mischoulon D, De Jong MF, Vitolo OV, Cusin C, Dording CM, Yeung AS, Durham K, Parkin SR, Fava M, Dougherty DD. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study. J Psychiatr Res. 2015 Nov; 70:98-105. PMID: 26424428.
    Citations: 1     Fields:    Translation:Humans
  56. Baek JH, Heo JY, Fava M, Mischoulon D, Nierenberg A, Hong JP, Roh S, Jeon HJ. Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder. J Affect Disord. 2015 Nov 15; 187:183-7. PMID: 26342171.
    Citations: 2     Fields:    Translation:Humans
  57. Cassano P, Cusin C, Mischoulon D, Hamblin MR, De Taboada L, Pisoni A, Chang T, Yeung A, Ionescu DF, Petrie SR, Nierenberg AA, Fava M, Iosifescu DV. Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study. Psychiatry J. 2015; 2015:352979. PMID: 26356811; PMCID: PMC4556873.
    Citations: 7     
  58. Williams A, Nakagawa A, Sado M, Fujisawa D, Mischoulon D, Smith F, Mimura M, Sato Y. Comparison of Initial Psychological Treatment Selections by US and Japanese Early-Career Psychiatrists for Patients with Major Depression: A Case Vignette Study. Acad Psychiatry. 2016 Apr; 40(2):235-41. PMID: 26268880; PMCID: PMC4762915.
    Citations:    Fields:    Translation:Humans
  59. Baek JH, Park JI, Ahn J, Roh SW, Heo JY, Fava M, Mischoulon D, Jeon HJ. Review of Suicide Prevention Programs: Massachusetts, United States, in Comparison with Seoul. Psychiatry Investig. 2015 Jul; 12(3):281-7. PMID: 26207119; PMCID: PMC4504908.
    Citations: 1     
  60. Yoo I, Woo JM, Lee SH, Fava M, Mischoulon D, Papakostas GI, Kim EJ, Chung S, Ha JH, Jeon HJ. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. J Affect Disord. 2015 Oct 01; 185:24-30. PMID: 26142691.
    Citations:    Fields:    Translation:Humans
  61. Myung W, Lee GH, Won HH, Fava M, Mischoulon D, Nyer M, Kim DK, Heo JY, Jeon HJ. Paraquat prohibition and change in the suicide rate and methods in South Korea. PLoS One. 2015; 10(6):e0128980. PMID: 26035175; PMCID: PMC4452788.
    Citations: 8     Fields:    Translation:Humans
  62. Mischoulon D. Novel approaches to study design and intervention for residual symptoms of MDD. J Clin Psychiatry. 2015 Jun; 76(6):e815-7. PMID: 26132691.
    Citations:    
  63. Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry. 2015 Jul; 48(4-5):141-4. PMID: 26011569.
    Citations: 4     Fields:    Translation:Humans
  64. Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A. College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity. Ann Clin Psychiatry. 2015 May; 27(2):100-8. PMID: 25954936; PMCID: PMC4539614.
    Citations: 1     Fields:    Translation:Humans
  65. Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB, Fava M, Mischoulon D. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evid Based Complement Alternat Med. 2015; 2015:949036. PMID: 25954318; PMCID: PMC4411442.
    Citations: 5     
  66. Simon NM, Walton ZE, Bui E, Prescott J, Hoge E, Keshaviah A, Schwarz N, Dryman T, Ojserkis RA, Kovachy B, Mischoulon D, Worthington J, De Vivo I, Fava M, Wong KK. Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology. 2015 Aug; 58:9-22. PMID: 25932992; PMCID: PMC4461511.
    Citations: 6     Fields:    Translation:HumansCells
  67. Rapaport MH, Nierenberg AA, Schettler PJ, Kinkead B, Cardoos A, Walker R, Mischoulon D. Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry. 2016 Jan; 21(1):71-9. PMID: 25802980; PMCID: PMC4581883.
    Citations: 25     Fields:    Translation:Humans
  68. Myung W, Won HH, Fava M, Mischoulon D, Yeung A, Lee D, Kim DK, Jeon HJ. Celebrity suicides and their differential influence on suicides in the general population: a national population-based study in Korea. Psychiatry Investig. 2015 Apr; 12(2):204-11. PMID: 25866521; PMCID: PMC4390591.
    Citations: 1     
  69. Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, Hibbeln J, Matsuoka Y, Mischoulon D, Mizoue T, Nanri A, Nishi D, Ramsey D, Rucklidge JJ, Sanchez-Villegas A, Scholey A, Su KP, Jacka FN. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015 Mar; 2(3):271-4. PMID: 26359904.
    Citations: 39     Fields:    Translation:Humans
  70. Nakagawa A, Williams A, Sado M, Oguchi Y, Mischoulon D, Smith F, Mimura M, Sato Y. Comparison of treatment selections by Japanese and US psychiatrists for major depressive disorder: A case vignette study. Psychiatry Clin Neurosci. 2015 Sep; 69(9):553-62. PMID: 25601043.
    Citations: 1     Fields:    Translation:Humans
  71. Heo JY, Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, Pisoni A, Papakostas GI. Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial. J Psychiatr Res. 2015 Mar; 62:56-61. PMID: 25659187.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  72. Mischoulon D, Nierenberg AA, Schettler PJ, Kinkead BL, Fehling K, Martinson MA, Hyman Rapaport M. A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J Clin Psychiatry. 2015 Jan; 76(1):54-61. PMID: 25272149.
    Citations: 10     Fields:    Translation:Humans
  73. Chen JA, Vijapura S, Papakostas GI, Parkin SR, Kim DJ, Cusin C, Baer L, Clain AJ, Fava M, Mischoulon D. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group. Asian J Psychiatr. 2015 Feb; 13:23-9. PMID: 25544195; PMCID: PMC4518843.
    Citations:    Fields:    Translation:HumansAnimals
  74. Jeon HJ, Lee C, Fava M, Mischoulon D, Shim EJ, Heo JY, Choi H, Park JH. Childhood trauma, parental death, and their co-occurrence in relation to current suicidality risk in adults: a nationwide community sample of Korea. J Nerv Ment Dis. 2014 Dec; 202(12):870-6. PMID: 25370752.
    Citations: 2     Fields:    Translation:Humans
  75. Jeon HJ, Kim JH, Kim BN, Park SJ, Fava M, Mischoulon D, Kang EH, Roh S, Lee D. Sleep quality, posttraumatic stress, depression, and human errors in train drivers: a population-based nationwide study in South Korea. Sleep. 2014 Dec 01; 37(12):1969-75. PMID: 25325495; PMCID: PMC4548517.
    Citations: 2     Fields:    Translation:Humans
  76. Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, DiPierro M, Cardoos A, Papakostas GI. Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial. Int Clin Psychopharmacol. 2014 Nov; 29(6):332-8. PMID: 24815673.
    Citations: 2     Fields:    Translation:Humans
  77. Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Fava M. Dr. Mischoulon and colleagues reply. J Clin Psychiatry. 2014 Nov; 75(11):e1328-9. PMID: 25470103.
    Citations:    Fields:    Translation:Humans
  78. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, Heo JY, Jeon HJ. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. J Affect Disord. 2014 Dec; 169:112-7. PMID: 25189990.
    Citations: 5     Fields:    Translation:HumansCells
  79. Jeon HJ, Park JI, Fava M, Mischoulon D, Sohn JH, Seong S, Park JE, Yoo I, Cho MJ. Feelings of worthlessness, traumatic experience, and their comorbidity in relation to lifetime suicide attempt in community adults with major depressive disorder. J Affect Disord. 2014 Sep; 166:206-12. PMID: 25012433.
    Citations: 3     Fields:    Translation:Humans
  80. Admon R, Nickerson LD, Dillon DG, Holmes AJ, Bogdan R, Kumar P, Dougherty DD, Iosifescu DV, Mischoulon D, Fava M, Pizzagalli DA. Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties. Psychol Med. 2015 Jan; 45(1):121-31. PMID: 25055809; PMCID: PMC4233014.
    Citations: 11     Fields:    Translation:Humans
  81. Jeon HJ, Walker RS, Inamori A, Hong JP, Cho MJ, Baer L, Clain A, Fava M, Mischoulon D. Differences in depressive symptoms between Korean and American outpatients with major depressive disorder. Int Clin Psychopharmacol. 2014 May; 29(3):150-6. PMID: 24323201.
    Citations: 7     Fields:    Translation:Humans
  82. Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry. 2014 Apr; 75(4):370-6. PMID: 24500245.
    Citations: 14     Fields:    Translation:Humans
  83. Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. J Affect Disord. 2014 Aug; 164:76-81. PMID: 24856557.
    Citations: 6     Fields:    Translation:Humans
  84. Jeon HJ, Woo JM, Lee SH, Kim EJ, Chung S, Ha JH, Fava M, Mischoulon D, Kim JH, Heo JY, Yu BH. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study. J Clin Psychopharmacol. 2014 Apr; 34(2):218-25. PMID: 24525660.
    Citations:    Fields:    Translation:Humans
  85. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 03; 51:113-8. PMID: 24495778.
    Citations: 8     Fields:    Translation:Humans
  86. Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D. Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. J Clin Psychopharmacol. 2013 Dec; 33(6):827-30. PMID: 24091858.
    Citations:    Fields:    Translation:HumansAnimals
  87. Nyer M, Doorley J, Durham K, Yeung AS, Freeman MP, Mischoulon D. What is the role of alternative treatments in late-life depression? Psychiatr Clin North Am. 2013 Dec; 36(4):577-96. PMID: 24229658.
    Citations: 3     Fields:    Translation:Humans
  88. Kim B, Kang ES, Fava M, Mischoulon D, Soskin D, Yu BH, Lee D, Lee DY, Park HD, Jeon HJ. Follicle-stimulating hormone (FSH), current suicidal ideation and attempt in female patients with major depressive disorder. Psychiatry Res. 2013 Dec 30; 210(3):951-6. PMID: 24080256.
    Citations: 3     Fields:    Translation:Humans
  89. Dording C, Cassiello C, King F, Pencina M, Fava M, Mischoulon D. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. Int Clin Psychopharmacol. 2013 Sep; 28(5):238-44. PMID: 23764521.
    Citations: 1     Fields:    Translation:Humans
  90. Desseilles M, Witte J, Chang TE, Iovieno N, Dording C, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Massachusetts General Hospital SAFER criteria for clinical trials and research. Harv Rev Psychiatry. 2013 Sep-Oct; 21(5):269-74. PMID: 24651559.
    Citations: 2     Fields:    Translation:Humans
  91. Jeon HJ, Hong JP, Fava M, Mischoulon D, Nyer M, Inamori A, Sohn JH, Seong S, Cho MJ. Childhood parental death and lifetime suicide attempt of the opposite-gender offspring in a nationwide community sample of Korea. Suicide Life Threat Behav. 2013 Dec; 43(6):598-610. PMID: 23834109.
    Citations: 6     Fields:    Translation:Humans
  92. Edwards E, Mischoulon D, Rapaport M, Stussman B, Weber W. Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am. 2013 Jul; 22(3):509-29, vii. PMID: 23806317.
    Citations: 3     Fields:    Translation:Humans
  93. Nyer M, Farabaugh A, Fehling K, Soskin D, Holt D, Papakostas GI, Pedrelli P, Fava M, Pisoni A, Vitolo O, Mischoulon D. Relationship between sleep disturbance and depression, anxiety, and functioning in college students. Depress Anxiety. 2013 Sep; 30(9):873-80. PMID: 23681944; PMCID: PMC3791314.
    Citations: 10     Fields:    Translation:Humans
  94. Cassano P, Chang T, Trinh NH, Baer L, Fava M, Mischoulon D. Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. J Affect Disord. 2013 Sep 05; 150(2):578-84. PMID: 23489398.
    Citations: 4     Fields:    Translation:Humans
  95. Cardoos A, Inamori A, Sanacora G, Fava M, Mischoulon D. Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report. Psychosomatics. 2013 Sep-Oct; 54(5):488-92. PMID: 23473447; PMCID: PMC3681895.
    Citations:    Fields:    Translation:Humans
  96. Mischoulon D, Freeman MP. Omega-3 fatty acids in psychiatry. Psychiatr Clin North Am. 2013 Mar; 36(1):15-23. PMID: 23538073.
    Citations: 10     Fields:    Translation:Humans
  97. Dording CM, LaRocca RA, Hails KA, Vitolo OV, Wisniewski SR, Balasubramani GK, Trivedi M, Fava M, Mischoulon D. The effect of sildenafil on quality of life. Ann Clin Psychiatry. 2013 Feb; 25(1):3-10. PMID: 23376864.
    Citations: 2     Fields:    Translation:Humans
  98. Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. J Clin Psychiatry. 2012 Dec; 73(12):1541-7. PMID: 23290327.
    Citations: 6     Fields:    Translation:Humans
  99. Witte J, Bentley K, Evins AE, Clain AJ, Baer L, Pedrelli P, Fava M, Mischoulon D. A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder. J Clin Psychopharmacol. 2012 Dec; 32(6):787-96. PMID: 23131884; PMCID: PMC3794470.
    Citations: 4     Fields:    Translation:Humans
  100. Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry. 2012 Dec; 169(12):1267-74. PMID: 23212058.
    Citations: 35     Fields:    Translation:Humans
  101. Sarris J, Moylan S, Camfield DA, Pase MP, Mischoulon D, Berk M, Jacka FN, Schweitzer I. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evid Based Complement Alternat Med. 2012; 2012:809653. PMID: 22969831; PMCID: PMC3434451.
    Citations: 7     
  102. Lin PY, Mischoulon D, Freeman MP, Matsuoka Y, Hibbeln J, Belmaker RH, Su KP. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry. 2012 Dec; 17(12):1161-3; author reply 1163-7. PMID: 22824812.
    Citations: 32     Fields:    Translation:Humans
  103. Wu J, Yeung AS, Schnyer R, Wang Y, Mischoulon D. Acupuncture for depression: a review of clinical applications. Can J Psychiatry. 2012 Jul; 57(7):397-405. PMID: 22762294.
    Citations: 12     Fields:    Translation:Humans
  104. Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M. Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment. CNS Spectr. 2012 Jun; 17(2):76-86. PMID: 22789065; PMCID: PMC4117348.
    Citations: 1     Fields:    Translation:Humans
  105. Sarris J, Fava M, Schweitzer I, Mischoulon D. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Pharmacopsychiatry. 2012 Nov; 45(7):275-8. PMID: 22592504.
    Citations: 3     Fields:    Translation:HumansAnimals
  106. Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI. Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. J Clin Psychiatry. 2012 Jun; 73(6):843-8. PMID: 22687580; PMCID: PMC4156851.
    Citations: 3     Fields:    Translation:Humans
  107. Jeon HJ, Kang ES, Lee EH, Jeong EG, Jeon JR, Mischoulon D, Lee D. Childhood trauma and platelet brain-derived neurotrophic factor (BDNF) after a three month follow-up in patients with major depressive disorder. J Psychiatr Res. 2012 Jul; 46(7):966-72. PMID: 22551661.
    Citations: 7     Fields:    Translation:Humans
  108. Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. J Affect Disord. 2012 Dec 10; 141(2-3):469-73. PMID: 22521855.
    Citations: 6     Fields:    Translation:Humans
  109. Dording CM, Dalton ED, Pencina MJ, Fava M, Mischoulon D. Comparison of academic and nonacademic sites in multi-center clinical trials. J Clin Psychopharmacol. 2012 Feb; 32(1):65-8. PMID: 22198440.
    Citations: 2     Fields:    Translation:Humans
  110. Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97. PMID: 22286203.
    Citations: 20     Fields:    Translation:Humans
  111. Cassano P, Fava M, Mischoulon D. Major depressive disorder with psychosis-like symptoms among Latinos. Psychiatr Serv. 2012; 63(5):482-7. PMID: 22422016.
    Citations: 2     Fields:    Translation:Humans
  112. Mischoulon D. The impact of omega-3 fatty acids on depressive disorders and suicidality: can we reconcile 2 studies with seemingly contradictory results? J Clin Psychiatry. 2011 Dec; 72(12):1574-6. PMID: 22244020; PMCID: PMC3735441.
    Citations: 4     Fields:    Translation:Humans
  113. Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. J Clin Psychiatry. 2011 Dec; 72(12):1669-76. PMID: 22053942.
    Citations: 15     Fields:    Translation:HumansAnimals
  114. Evins AE, Pachas G, Mischoulon D, Urbanoski K, Carlini S, Sousa J, Bentley K, Rigotti NA, Nino-Gomez J, Loebl T, Janes AC, Kaufman MJ, Fava M. A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. J Clin Psychopharmacol. 2011 Oct; 31(5):597-602. PMID: 21869693; PMCID: PMC3741043.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  115. Mischoulon D. Can you recommend anything for dysthymia? Harv Ment Health Lett. 2011 Oct; 28(4):5. PMID: 22125827.
    Citations:    Fields:    Translation:Humans
  116. Mischoulon D. What is maca root? Harv Ment Health Lett. 2011 Oct; 28(4):5. PMID: 22125826.
    Citations:    Fields:    Translation:HumansAnimals
  117. Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7. PMID: 21939613.
    Citations: 2     Fields:    Translation:Humans
  118. Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. J Affect Disord. 2012 Feb; 136(3):1174-8. PMID: 21911258.
    Citations: 9     Fields:    Translation:Humans
  119. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2012 Jan; 73(1):81-6. PMID: 21903025.
    Citations: 38     Fields:    Translation:Humans
  120. Desseilles M, Witte J, Chang TE, Iovieno N, Dording CM, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Assessing the adequacy of past antidepressant trials: a clinician's guide to the antidepressant treatment response questionnaire. J Clin Psychiatry. 2011 Aug; 72(8):1152-4. PMID: 21899818.
    Citations: 4     Fields:    Translation:Humans
  121. Sarris J, Mischoulon D, Schweitzer I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord. 2011 Aug-Sep; 13(5-6):454-65. PMID: 22017215.
    Citations: 13     Fields:    Translation:Humans
  122. Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. Int Clin Psychopharmacol. 2011 Jul; 26(4):206-12. PMID: 21278577; PMCID: PMC3111899.
    Citations: 1     Fields:    Translation:HumansAnimals
  123. Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. Eur Psychiatry. 2012 Oct; 27(7):518-21. PMID: 21665441.
    Citations: 1     Fields:    Translation:Humans
  124. Rapaport MH, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D. The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res. 2011 Jul; 45(7):931-41. PMID: 21632064; PMCID: PMC3137264.
    Citations: 7     Fields:    Translation:HumansAnimals
  125. Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI. SAMe and sexual functioning. Eur Psychiatry. 2012 Aug; 27(6):451-4. PMID: 21398094.
    Citations: 5     Fields:    Translation:Humans
  126. Mischoulon D, Eddy KT, Keshaviah A, Dinescu D, Ross SL, Kass AE, Franko DL, Herzog DB. Depression and eating disorders: treatment and course. J Affect Disord. 2011 May; 130(3):470-7. PMID: 21109307; PMCID: PMC3085695.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  127. Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. J Clin Psychiatry. 2011 Apr; 72(4):473-9. PMID: 21208574.
    Citations: 9     Fields:    Translation:Humans
  128. Fava M, Mischoulon D. Evidence for folate in combination with antidepressants at initiation of therapy. J Clin Psychiatry. 2010 Nov; 71(11):e31. PMID: 21114944.
    Citations:    Fields:    Translation:HumansPHPublic Health
  129. Yeung AS, Ameral VE, Chuzi SE, Fava M, Mischoulon D. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. J Affect Disord. 2011 Apr; 130(1-2):285-9. PMID: 20692042.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  130. Farabaugh A, Sonawalla S, Johnson DP, Witte J, Papakostas GI, Goodness T, Clain A, Baer L, Mischoulon D, Fava M, Harley R. Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment. Ann Clin Psychiatry. 2010 Aug; 22(3):166-71. PMID: 20680189.
    Citations: 3     Fields:    Translation:Humans
  131. Dording CM, Mischoulon D, Goodness TM, Baer L, Clain A, Stewart JW, Matthews JD, McGrath PJ, Nierenberg AA, Fava M, Papakostas GI. Psychoticism and paranoid ideation in patients with nonpsychotic major depressive disorder: prevalence, response to treatment, and impact on short- and long-term treatment outcome. CNS Spectr. 2010 Aug; 15(8):515-21. PMID: 20703198.
    Citations: 1     Fields:    Translation:Humans
  132. Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry. 2010 Aug; 167(8):942-8. PMID: 20595412.
    Citations: 33     Fields:    Translation:Humans
  133. Farabaugh AH, Bitran S, Witte J, Alpert J, Chuzi S, Clain AJ, Baer L, Fava M, McGrath PJ, Dording C, Mischoulon D, Papakostas GI. Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome. Int Clin Psychopharmacol. 2010 Jul; 25(4):214-7. PMID: 20400905; PMCID: PMC2909033.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  134. Iovieno N, Dalton ED, Fava M, Mischoulon D. Second-tier natural antidepressants: review and critique. J Affect Disord. 2011 May; 130(3):343-57. PMID: 20579741.
    Citations: 5     Fields:    Translation:HumansAnimals
  135. Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. J Clin Psychiatry. 2010 Jun; 71(6):682-8. PMID: 20573327.
    Citations: 14     Fields:    Translation:Humans
  136. Freeman MP, Fava M, Lake J, Trivedi MH, Wisner KL, Mischoulon D. Complementary and alternative medicine in major depressive disorder: the American Psychiatric Association Task Force report. J Clin Psychiatry. 2010 Jun; 71(6):669-81. PMID: 20573326.
    Citations: 15     Fields:    Translation:HumansAnimals
  137. Nierenberg AA, Rapaport MH, Schettler PJ, Howland RH, Smith JA, Edwards D, Schneider T, Mischoulon D. Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V. CNS Neurosci Ther. 2010 Aug; 16(4):208-16. PMID: 20236139.
    Citations: 7     Fields:    Translation:Humans
  138. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Obstet Gynecol Clin North Am. 2009 Dec; 36(4):789-807, x. PMID: 19944301; PMCID: PMC2786903.
    Citations: 3     Fields:    Translation:HumansAnimals
  139. Miller KK, Perlis RH, Papakostas GI, Mischoulon D, Losifescu DV, Brick DJ, Fava M. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. CNS Spectr. 2009 Dec; 14(12):688-94. PMID: 20394176; PMCID: PMC4081446.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  140. Mischoulon D, Pedrelli P, Wurtman J, Vangel M, Wurtman R. Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD). CNS Neurosci Ther. 2010; 16(1):13-24. PMID: 19769596.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  141. Targum SD, Mischoulon D. The status of nutraceuticals for the treatment of depression. Psychiatry (Edgmont). 2009 Sep; 6(9):46-8. PMID: 19855861; PMCID: PMC2766289.
    Citations:    
  142. Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston AM, Smith J, Beaumont EC, Dahan LE, Alpert JE, Nierenberg AA, Fava M. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009 Dec; 70(12):1636-44. PMID: 19709502; PMCID: PMC2918427.
    Citations: 24     Fields:    Translation:Humans
  143. Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol. 2009 Nov; 19(11):772-7. PMID: 19574030.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  144. Fava M, Mischoulon D. Folate in depression: efficacy, safety, differences in formulations, and clinical issues. J Clin Psychiatry. 2009; 70 Suppl 5:12-7. PMID: 19909688.
    Citations: 9     Fields:    Translation:Humans
  145. Dording CM, Sinicropi-Yao L, Papakostas G, Matthews JD, Nierenberg AA, Fava M, Mischoulon D. The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder. Nord J Psychiatry. 2009; 63(5):420-5. PMID: 19521922.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  146. Mischoulon D, Fava M. Are nutritional supplements ready for prime time? J Clin Psychiatry. 2008 Sep; 69(9):1497-8. PMID: 19193349.
    Citations: 2     Fields:    Translation:HumansAnimals
  147. Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res. 2008 Oct 30; 161(1):116-20. PMID: 18755514.
    Citations: 9     Fields:    Translation:Humans
  148. Howland RH, Schettler PJ, Rapaport MH, Mischoulon D, Schneider T, Fasiczka A, Delrahiem K, Maddux R, Lightfoot M, Nierenberg AA. Clinical features and functioning of patients with minor depression. Psychother Psychosom. 2008; 77(6):384-9. PMID: 18716424.
    Citations: 15     Fields:    Translation:Humans
  149. Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry. 2008 Sep 15; 64(6):455-60. PMID: 18571625.
    Citations: 11     Fields:    Translation:Humans
  150. Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008 Sep; 18(9):639-45. PMID: 18539007.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  151. Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neurosci Ther. 2008; 14(3):182-91. PMID: 18801111.
    Citations: 8     Fields:    Translation:HumansAnimals
  152. Yeung A, Mischoulon D, Alpert J, Ma Y, Fava M. Acupuncture for major depressive disorder: has its efficacy been disproved? J Clin Psychiatry. 2007 Oct; 68(10):1617; author reply 1617-8. PMID: 17960982.
    Citations: 2     Fields:    Translation:Humans
  153. Petersen T, Fava M, Alpert JE, Vorono S, Sanders KM, Mischoulon D. Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates. Acad Psychiatry. 2007 Jul-Aug; 31(4):281-9. PMID: 17626190.
    Citations: 1     Fields:    Translation:Humans
  154. Mischoulon D. Update and critique of natural remedies as antidepressant treatments. Psychiatr Clin North Am. 2007 Mar; 30(1):51-68. PMID: 17362803.
    Citations: 4     Fields:    Translation:HumansAnimals
  155. Mischoulon D, Raab MF. The role of folate in depression and dementia. J Clin Psychiatry. 2007; 68 Suppl 10:28-33. PMID: 17900207.
    Citations: 10     Fields:    Translation:Humans
  156. Farabaugh A, Mischoulon D, Schwartz F, Pender M, Fava M, Alpert J. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD. Depress Anxiety. 2007; 24(6):433-9. PMID: 17086540.
    Citations: 2     Fields:    Translation:Humans
  157. Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Marangell LB, Richardson AJ, Lake J, Stoll AL. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006 Dec; 67(12):1954-67. PMID: 17194275.
    Citations: 140     Fields:    Translation:Humans
  158. Farabaugh AH, Sonawalla SB, Fava M, Pedrelli P, Papakostas GI, Schwartz F, Mischoulon D. Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis. Hum Psychopharmacol. 2006 Jun; 21(4):221-5. PMID: 16783809.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  159. Papakostas GI, Worthington JJ, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, Homberger CH, Mischoulon D, Fava M. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depress Anxiety. 2006; 23(3):178-81. PMID: 16528701.
    Citations: 9     Fields:    Translation:Humans
  160. Fraguas R, Papakostas GI, Mischoulon D, Bottiglieri T, Alpert J, Fava M. Anger attacks in major depressive disorder and serum levels of homocysteine. Biol Psychiatry. 2006 Aug 01; 60(3):270-4. PMID: 16325154.
    Citations: 5     Fields:    Translation:Humans
  161. Mischoulon D, Lagomasino IT, Harmon C. Atypical psychotic symptoms in a Hispanic population: diagnostic dilemmas and implications for treatment. Psychiatry (Edgmont). 2005 Oct; 2(10):38-46. PMID: 21120089; PMCID: PMC2993517.
    Citations: 1     
  162. Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol. 2005 Oct; 25(5):441-7. PMID: 16160619.
    Citations: 19     Fields:    Translation:HumansAnimalsCTClinical Trials
  163. Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry. 2005 Aug; 66(8):1038-42. PMID: 16086620.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  164. Farabaugh A, Fava M, Mischoulon D, Sklarsky K, Petersen T, Alpert J. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Compr Psychiatry. 2005 Jul-Aug; 46(4):266-71. PMID: 16175757.
    Citations: 8     Fields:    Translation:Humans
  165. Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol. 2005 Dec; 8(4):523-8. PMID: 15877935.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  166. Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients. Int Clin Psychopharmacol. 2005 Mar; 20(2):87-91. PMID: 15729083.
    Citations: 7     Fields:    Translation:HumansAnimalsCTClinical Trials
  167. Yeung A, Kung WW, Murakami JL, Mischoulon D, Alpert JE, Nierenberg AA, Fava M. Outcomes of recognizing depressed Chinese American patients in primary care. Int J Psychiatry Med. 2005; 35(3):213-24. PMID: 16480237.
    Citations: 5     Fields:    Translation:Humans
  168. Alpert JE, Papakostas G, Mischoulon D, Worthington JJ, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol. 2004 Dec; 24(6):661-4. PMID: 15538131.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  169. Farabaugh AH, Mischoulon D, Fava M, Green C, Guyker W, Alpert J. The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD). Acta Psychiatr Scand. 2004 Dec; 110(6):465-70. PMID: 15521832.
    Citations: 7     Fields:    Translation:Humans
  170. Farabaugh A, Mischoulon D, Fava M, Guyker W, Alpert J. The overlap between personality disorders and major depressive disorder (MDD). Ann Clin Psychiatry. 2004 Oct-Dec; 16(4):217-24. PMID: 15702570.
    Citations: 2     Fields:    Translation:Humans
  171. Murck H, Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Mannel M, Rosenbaum JF. Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo. Int J Neuropsychopharmacol. 2005 Jun; 8(2):215-21. PMID: 15458612.
    Citations:    Fields:    Translation:HumansAnimalsCTClinical Trials
  172. Papakostas GI, Petersen T, Mischoulon D, Green CH, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry. 2004 Aug; 65(8):1096-8. PMID: 15323595.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  173. Papakostas GI, Petersen T, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Rosenbaum JF, Alpert JE, Fava M. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004 Aug; 65(8):1090-5. PMID: 15323594.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  174. Yeung A, Kung WW, Chung H, Rubenstein G, Roffi P, Mischoulon D, Fava M. Integrating psychiatry and primary care improves acceptability to mental health services among Chinese Americans. Gen Hosp Psychiatry. 2004 Jul-Aug; 26(4):256-60. PMID: 15234819.
    Citations: 9     Fields:    Translation:Humans
  175. Papakostas GI, Ongür D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004 Mar; 14(2):135-42. PMID: 15013029.
    Citations: 19     Fields:    Translation:HumansAnimals
  176. Mischoulon D, Beresin EV. "The Matrix": An allegory of the psychoanalytic journey. Acad Psychiatry. 2004; 28(1):71-7. PMID: 15140812.
    Citations: 1     Fields:    Translation:Humans
  177. Yeung A, Chan R, Mischoulon D, Sonawalla S, Wong E, Nierenberg AA, Fava M. Prevalence of major depressive disorder among Chinese-Americans in primary care. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):24-30. PMID: 14757299.
    Citations: 13     Fields:    Translation:Humans
  178. Mischoulon D, Opitz G, Kelly K, Fava M, Rosenbaum JF. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment. Depress Anxiety. 2004; 19(1):43-50. PMID: 14978785.
    Citations: 2     Fields:    Translation:Humans
  179. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):13-7. PMID: 14757297.
    Citations: 53     Fields:    Translation:Humans
  180. Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF, Fava M. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day. Acta Psychiatr Scand. 2003 Dec; 108(6):432-8. PMID: 14616224.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  181. Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, Rosenbaum JF, Fava M. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry. 2003 Nov 01; 54(9):879-83. PMID: 14573314.
    Citations: 28     Fields:    Translation:Humans
  182. Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Res. 2003 May 30; 118(2):137-45. PMID: 12798978.
    Citations: 4     Fields:    Translation:Humans
  183. Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA. Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. Compr Psychiatry. 2003 Jan-Feb; 44(1):44-50. PMID: 12524635.
    Citations: 4     Fields:    Translation:Humans
  184. Mischoulon D, Dougherty DD, Bottonari KA, Gresham RL, Sonawalla SB, Fischman AJ, Fava M. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding. Psychiatry Res. 2002 Dec 30; 116(3):151-61. PMID: 12477599.
    Citations: 5     Fields:    Translation:HumansCells
  185. Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. J Clin Psychiatry. 2002 Dec; 63(12):1164-70. PMID: 12523877.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  186. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr. 2002 Nov; 76(5):1158S-61S. PMID: 12420702.
    Citations: 31     Fields:    Translation:Humans
  187. Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M. The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Ann Clin Psychiatry. 2002 Sep; 14(3):143-7. PMID: 12585563.
    Citations: 20     Fields:    Translation:Humans
  188. Farabaugh A, Mischoulon D, Yeung A, Alpert J, Matthews J, Pava J, Fava M. Predictors of stable personality disorder diagnoses in outpatients with remitted depression. J Nerv Ment Dis. 2002 Apr; 190(4):248-56. PMID: 11960086.
    Citations: 4     Fields:    Translation:Humans
  189. Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002 Mar; 14(1):33-8. PMID: 12046638.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  190. Mischoulon D, McColl-Vuolo R, Howarth S, Lagomasino IT, Alpert JE, Nierenberg AA, Fava M. Management of major depression in the primary care setting. Psychother Psychosom. 2001 Mar-Apr; 70(2):103-7. PMID: 11244391.
    Citations: 4     Fields:    Translation:Humans
  191. Mischoulon D, Fava M. Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatr Clin North Am. 2000 Dec; 23(4):785-94. PMID: 11147247.
    Citations: 8     Fields:    Translation:Humans
  192. Mischoulon D, Burger JK, Spillmann MK, Worthington JJ, Fava M, Alpert JE. Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression. J Psychosom Res. 2000 Sep; 49(3):183-7. PMID: 11110989.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  193. Alpert JE, Mischoulon D, Nierenberg AA, Fava M. Nutrition and depression: focus on folate. Nutrition. 2000 Jul-Aug; 16(7-8):544-6. PMID: 10906550.
    Citations: 16     Fields:    Translation:Humans
  194. Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry. 2000 Jun; 45(5):476-81. PMID: 10900529.
    Citations: 14     Fields:    Translation:Humans
  195. Mischoulon D. Antidepressants: choices and controversy. Health News. 2000 Jun; 6(6):4-5. PMID: 10865517.
    Citations:    Fields:    Translation:Humans
  196. Mischoulon D, Fava M, Rosenbaum JF. Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 1999 Mar-Apr; 6(6):322-6. PMID: 10370439.
    Citations:    Fields:    Translation:Humans
  197. Mischoulon D, Rosenbaum JF. The use of natural remedies in psychiatry: a commentary. Harv Rev Psychiatry. 1999 Jan-Feb; 6(5):279-83. PMID: 10372293.
    Citations: 1     Fields:    Translation:Humans
  198. Rana B, Xie Y, Mischoulon D, Bucher NL, Farmer SR. The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle. J Biol Chem. 1995 Jul 28; 270(30):18123-32. PMID: 7629124.
    Citations: 19     Fields:    Translation:AnimalsCells
  199. Rana B, Mischoulon D, Xie Y, Bucher NL, Farmer SR. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Mol Cell Biol. 1994 Sep; 14(9):5858-69. PMID: 8065319; PMCID: PMC359112.
    Citations: 45     Fields:    Translation:AnimalsCells
  200. Mischoulon D, Rana B, Kotliar N, Pilch PF, Bucher NL, Farmer SR. Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes. J Cell Physiol. 1992 Nov; 153(2):288-96. PMID: 1429849.
    Citations: 4     Fields:    Translation:AnimalsCells
  201. Mischoulon D, Rana B, Bucher NL, Farmer SR. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol Cell Biol. 1992 Jun; 12(6):2553-60. PMID: 1588957; PMCID: PMC364448.
    Citations: 32     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mischoulon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (464)
Explore
_
Co-Authors (79)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
©2019 President and Fellows of Harvard College
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.